Indeed, the BCR isolate is profoundly resistance to the 3 classes of anthelmintic that are currently used for treatment of canine and zoonotic hookworm infections, which will complicate treatment of hookworm infections should they become widespread. This evidence concerns the gene BCR and ancylostomiasis.